Nifekalant enlarged the transmural activation-recovery interval difference as well as the peak-to-end interval on surface ECG in a patient with short-QT syndrome

Journal of Cardiovascular Electrophysiology

Volumn 23, Issue 8, 2012, Pages 877-880

  Chinushi, Masaomi ^a   Sato, Akinori ^a   Izumi, Daisuke ^a   Furushima, Hiroshi ^a  

^a NIIGATA UNIVERSITY   (Japan)

Author keywords

nifekalant; QT interval; short QT syndrome; sudden death; transmural repolarization

Indexed keywords

NIFEKALANT;

ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; CARDIOVASCULAR PARAMETERS; CASE REPORT; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY; FEMALE; HEART ATRIUM PACING; HEART LEFT VENTRICLE; HEART REPOLARIZATION; HUMAN; PEAK TO END INTERVAL; PRIORITY JOURNAL; QT INTERVAL; SHORT QT SYNDROME; SYNCOPE; T WAVE; TRANSMURAL ACTIVATION INTERVAL DISPERSION;

ACTION POTENTIALS; ADOLESCENT; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; CARDIAC PACING, ARTIFICIAL; ELECTROCARDIOGRAPHY; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; FATAL OUTCOME; FEMALE; HEART CONDUCTION SYSTEM; HEART DEFECTS, CONGENITAL; HEART RATE; HUMANS; PREDICTIVE VALUE OF TESTS; PYRIMIDINONES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84866140239     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2012.02292.x     Document Type: Article

References (16)

1. Gaita F, Giustetto C, Bianchi F, Schimpf R, Haissaguerre M, Calò L, Brugada R, Antzelevitch C, Borggrefe M, Wolpert C,: Short QT syndrome: Pharmacological treatment. J Am Coll Cardiol 2004; 43: 1494-1499.
2. Giustetto C, Schimpf R, Mazzanti A, Scrocco C, Maury P, Anttonen O, Probst V, Blanc JJ, Sbragia P, Dalmasso P, Borggrefe M, Gaita F,: Long-term follow-up of patients with short QT syndrome. J Am Coll Cardiol 2011; 58: 587-595.
3. Patel C, Yan GX, Antzelevitch C,: Short QT syndrome: From bench to bedside. Circ Arrhythm Electrophysiol 2010; 3: 401-408.
4. Rautaharju PM, Zhang ZM,: Linearly scaled, rate-invariant normal limits for QT interval: Eight decades of incorrect application of power functions. J Cardiovasc Electrophysiol 2002; 13: 1211-1218.
5. Chinushi M, Tagawa M, Kasai H, Washizuka T, Abe A, Furushima H, Aizawa Y,: Correlation between the effective refractory period and activation-recovery interval calculated from the intracardiac unipolar electrogram of humans with and without dl-sotalol treatment. Jpn Circ J 2001; 65: 702-706.
6. Chinushi M, Washizuka T, Hosaka Y, Furushima H, Tanabe Y, Chinushi Y, Aizawa Y,: Activation-recovery interval as a parameter to assess the intracardiac ventricular repolarization in patients with congenital long QT syndrome. Am J Cardiol 2002; 90: 432-435.
7. Gupta P, Patel C, Patel H, Narayanaswamy S, Malhotra B, Green JT, Yan GX,: T(p-e)/QT ratio as an index of arrhythmogenesis. J Electrocardiol 2008; 41: 567-574.
8. Gollob MH, Redpath CJ, Roberts JD,: The short QT syndrome: Proposed diagnostic criteria. J Am Coll Cardiol 2011; 57: 802-812.
9. Patel C, Antzelevitch C,: Cellular basis for arrhythmogenesis in an experimental model of the SQT1 form of the short QT syndrome. Heart Rhythm 2008; 5: 585-590.
10. Sicouri S, Fish J, Antzelevitch C,: Distribution of M cells in the canine ventricle. J Cardiovasc Electrophysiol 1994; 5: 824-837.
11. Wolpert C, Schimpf R, Giustetto C, Antzelevitch C, Cordeiro J, Dumaine R, Brugada R, Hong K, Bauersfeld U, Gaita F, Borggrefe M,: Further insights into the effect of quinidine in short QT syndrome caused by a mutation in HERG. J Cardiovasc Electrophysiol 2005; 16: 54-58.
12. Bjerregaard P, Gussak I,: Short QT syndrome: Mechanisms, diagnosis and treatment. Nat Clin Pract Cardiovasc Med 2005; 2: 84-87.
13. Milberg P, Tegelkamp R, Osada N, Schimpf R, Wolpert C, Breithardt G, Borggrefe M, Eckardt L,: Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome. J Cardiovasc Electrophysiol 2007; 18: 658-664.
14. Giustetto C, Di Monte F, Wolpert C, Borggrefe M, Schimpf R, Sbragia P, Leone G, Maury P, Anttonen O, Haissaguerre M, Gaita F,: Short QT syndrome: Clinical findings and diagnostic-therapeutic implications. Eur Heart J 2006; 27: 2440-2447.
15. Sun Y, Quan XQ, Fromme S, Cox RH, Zhang P, Zhang L, Guo D, Guo J, Patel C, Kowey PR, Yan GX,: A novel mutation in the KCNH2 gene associated with short QT syndrome. J Mol Cell Cardiol 2011; 50: 433-441.
16. Takenaka K, Ai T, Shimizu W, Kobori A, Ninomiya T, Otani H, Kubota T, Takaki H, Kamakura S, Horie M,: Exercise stress test amplifies genotype-phenotype correlation in the LQT1 and LQT2 forms of the long-QT syndrome. Circulation 2003; 107: 838-844.